Aveanna Healthcare Holdings, Inc. — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
This is an investor presentation (not a material event filing) containing 2026 YTD financial results and forward-looking guidance. Key metrics: consolidated revenue $2.68B (YTD 2026 annualized), Adjusted EBITDA $365M, 30,000 caregivers, 403 locations in 39 states. Q2 2026 revenue $670.5M (13.7% YoY growth), free cash flow $75.4M YTD (up $38.5M vs 2025). No counterparties, M&A, financing, leadership changes, or material transactions are disclosed—this is routine quarterly guidance and market positioning.
Why this rating
Routine investor presentation disclosing standard quarterly results and long-term targets (5–7% organic, 8–11% M&A growth). No material transaction, deal, or change disclosed relative to $349.7M market cap.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.